| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | importazole | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 0.2 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.066 | 0.2 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.04 | 0.2 |